Kenneth J. O'Byrne

Familiar drugs may prevent cancer

K. O'Byrne, A. Gescher, W. Steward, 2001, Postgraduate medical journal.

Angiogenesis and non-small cell lung cancer.

K. O'Byrne, W. Steward, R. Walker, 2000, Lung cancer.

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.

K. O'Byrne, W. Steward, R. Sharma, 2006, European journal of cancer.

Angiogenesis as a biomarker and target in cancer chemoprevention.

K. O'Byrne, W. Steward, R. Sharma, 2001, The Lancet. Oncology.

Inflammation and cancer: the role of the immune response and angiogenesis.

K. O'Byrne, A. Dalgleish, Kenneth J. O'Byrne, 2006, Cancer treatment and research.